Published in J Neurol Neurosurg Psychiatry on July 18, 2010
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care (2016) 1.43
Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med (2013) 1.15
Clinical review: Traumatic brain injury in patients receiving antiplatelet medication. Crit Care (2012) 0.94
Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study. Crit Care (2013) 0.87
A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage. BMJ Open (2012) 0.82
Derivation of a Predictive Score for Hemorrhagic Progression of Cerebral Contusions in Moderate and Severe Traumatic Brain Injury. Neurocrit Care (2016) 0.75
Effects of Pre-Injury Anti-Platelet Agents on Short-Term Outcome of Patients with Mild Traumatic Brain Injury: A Cohort Study. Bull Emerg Trauma (2017) 0.75
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology (2010) 5.24
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology (2005) 5.11
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology (2005) 4.86
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology (2008) 4.28
A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol (2010) 3.53
Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology (2005) 3.44
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol (2013) 3.20
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol (2005) 3.17
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology (2012) 3.04
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology (2008) 2.91
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology (2009) 2.87
Clearance of the cervical spine in clinically unevaluable trauma patients. Spine (Phila Pa 1976) (2010) 2.65
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology (2004) 2.41
Cost-effectiveness of current treatment strategies for lumbar spinal stenosis: nonsurgical care, laminectomy, and X-STOP. J Neurosurg Spine (2010) 2.32
Is aggressive treatment of traumatic brain injury cost-effective? J Neurosurg (2012) 2.22
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Diabetes Care (2011) 2.16
Surgical management of acute subdural hematomas. Neurosurgery (2006) 2.11
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology (2009) 2.07
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obes Res (2005) 2.04
Traumatic encephalocele related to orbital roof fractures: report of six cases and literature review. Surg Neurol (2002) 2.00
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. J Sex Med (2014) 1.99
Utility of delayed surgical repair of neonatal brachial plexus palsy. J Neurosurg Pediatr (2014) 1.97
Anterior surgical management of single-level cervical disc disease: a cost-effectiveness analysis. Spine (Phila Pa 1976) (2014) 1.96
Surgical management of acute epidural hematomas. Neurosurgery (2006) 1.90
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol (2010) 1.78
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab (2005) 1.73
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology (2009) 1.71
Combined endoscopic transsphenoidal-transventricular approach for resection of a giant pituitary macroadenoma. World Neurosurg (2010) 1.69
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology (2008) 1.68
ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr (2009) 1.63
Surgical management of traumatic parenchymal lesions. Neurosurgery (2006) 1.61
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut (2010) 1.59
Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis. Addiction (2012) 1.58
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care (2007) 1.58
Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. Expert Opin Pharmacother (2011) 1.55
Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Nutr Metab (Lond) (2010) 1.46
Durability of Roux-en-Y gastric bypass surgery: a meta-regression study. Ann Surg (2012) 1.44
Decompressive hemicraniectomy for pediatric traumatic brain injury: long-term outcome based on quality of life. Pediatr Neurosurg (2011) 1.44
Geographic variation in outcomes from severe traumatic brain injury. World Neurosurg (2011) 1.44
How large is the typical subarachnoid hemorrhage? A review of current neurosurgical knowledge. World Neurosurg (2011) 1.41
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol (2007) 1.41
Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma (2008) 1.40
Metabolic syndrome and health-related quality of life: does psychological well-being matter? Ann Epidemiol (2008) 1.40
Compulsive exercise to control shape or weight in eating disorders: prevalence, associated features, and treatment outcome. Compr Psychiatry (2008) 1.37
A critical comparison of clinical decision instruments for computed tomographic scanning in mild closed traumatic brain injury in adolescents and adults. Ann Emerg Med (2008) 1.35
Choosing the best operation for chronic subdural hematoma: a decision analysis. J Neurosurg (2010) 1.33
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol (2008) 1.28
uPA modulates the age-dependent effect of brain injury on cerebral hemodynamics through LRP and ERK MAPK. J Cereb Blood Flow Metab (2008) 1.18
Factors associated with neurological outcome and lesion progression in traumatic subarachnoid hemorrhage patients. Neurosurgery (2005) 1.18
Clinical value of decompressive craniectomy. N Engl J Med (2011) 1.18
Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis (2007) 1.16
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol (2004) 1.16
Evidence-based diagnosis of nontraumatic headache in the emergency department: a consensus statement on four clinical scenarios. Headache (2004) 1.16
Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl (2008) 1.11
Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity. J Obes (2010) 1.11
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther (2008) 1.11
Screening tests for normal-pressure hydrocephalus: sensitivity, specificity, and cost. J Neurosurg (2006) 1.11
uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK. Brain Res (2008) 1.09
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery (2008) 1.05
NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology (2002) 1.04
Lifestyle modification in the management of the metabolic syndrome: achievements and challenges. Diabetes Metab Syndr Obes (2010) 1.03
The management of patients with intradural post-traumatic mass lesions: a multicenter survey of current approaches to surgical management in 729 patients coordinated by the European Brain Injury Consortium. Neurosurgery (2005) 1.03
Psychological variables associated with weight loss in obese patients seeking treatment at medical centers. J Am Diet Assoc (2009) 1.02
Construct validity of the Short Form-36 Health Survey and its relationship with BMI in obese outpatients. Obesity (Silver Spring) (2006) 1.02
Weight loss expectations in obese patients seeking treatment at medical centers. Obes Res (2004) 1.02
Surgical management of depressed cranial fractures. Neurosurgery (2006) 1.01
Traumatic coagulopathy: the effect of brain injury. J Neurotrauma (2008) 1.00
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis (2007) 0.98
Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders. J Neurochem (2010) 0.98
Clinical and psychological correlates of health-related quality of life in obese patients. Health Qual Life Outcomes (2010) 0.97
Glucagon-like peptide 1-based drugs and pancreatic safety. JAMA Intern Med (2013) 0.96
Night eating syndrome and weight loss outcome in obese patients. Int J Eat Disord (2011) 0.95
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Curr Diab Rep (2007) 0.95
The effect of lifestyle changes in non-alcoholic fatty liver disease. Dig Dis (2010) 0.95
Pediatric intracranial arachnoid cysts: comparative effectiveness of surgical treatment options. Childs Nerv Syst (2013) 0.93
Risk stratification of non-traumatic headache in the emergency department. J Neurol (2009) 0.93
Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report. Diabetes Care (2010) 0.93
Psychological distress in morbid obesity in relation to weight history. Obes Surg (2007) 0.93
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. J Hepatol (2012) 0.92
Cost-effectiveness of confirmatory techniques for the placement of lumbar pedicle screws. Neurosurg Focus (2012) 0.92
Use of "custom made" porous hydroxyapatite implants for cranioplasty: postoperative analysis of complications in 1549 patients. Surg Neurol Int (2013) 0.92
Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab Syndr Obes (2012) 0.91
Morphometric analysis of posterior fossa after in utero myelomeningocele repair. J Neurosurg Pediatr (2011) 0.91
Major factors for facilitating change in behavioral strategies to reduce obesity. Psychol Res Behav Manag (2013) 0.90
Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS One (2011) 0.90
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem. Appetite (2009) 0.90
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol (2013) 0.90
Is amenorrhea a clinically useful criterion for the diagnosis of anorexia nervosa? Behav Res Ther (2008) 0.90
Gender, fatty liver and GGT. Hepatology (2006) 0.89
Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection. Antivir Ther (2009) 0.89
Physical activity for the prevention and treatment of metabolic disorders. Intern Emerg Med (2013) 0.89
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One (2012) 0.89
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One (2013) 0.88
Prevalence of cervical spinal injury in trauma. Neurosurg Focus (2008) 0.88
Metabolic syndrome and insulin resistance in subjects with morbid obesity. Obes Surg (2009) 0.88
The value of the calcium binding protein S100 in the management of patients with traumatic brain injury. Acta Biomed (2012) 0.88
Relating quality of life to Glasgow outcome scale health states. J Neurotrauma (2012) 0.88